Acadia Healthcare Company, Inc. (BIT:1ACHC)
Italy · Delayed Price · Currency is EUR | Market Cap | 2.48B +51.4% |
| Revenue (ttm) | 2.95B +4.3% |
| Net Income | -985.80M |
| EPS | -10.89 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 18.60 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | 27.00 |
| Day's Range | n/a |
| 52-Week Range | 9.90 - 31.20 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 28, 2026 |
About Acadia Healthcare Company
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and i... [Read more]
News
Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
Acadia Healthcare Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigat...
Robbins LLP Notifies Acadia Healthcare (ACHC) Investors that the Lawsuit Survived Defendants' Motion to Dismiss - Contact Robbins LLP for Information
SAN DIEGO, July 31, 2026 /PRNewswire/ -- Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to pro...
Acadia Healthcare Company Earnings Call Transcript: Q2 2026
Second quarter results met or exceeded guidance, with strong free cash flow, disciplined capital deployment, and accelerated ramp-up at new facilities. Revenue was flat year-over-year but grew 2.8% after normalizing for supplemental payments. Leadership changes and operational focus are driving improved execution.
Acadia Healthcare Company Quarterly report: Q2 2026
Acadia Healthcare Company has published its Q2 2026 quarterly earnings report on July 29, 2026.
Acadia Healthcare Company Earnings release: Q2 2026
Acadia Healthcare Company released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Acadia Healthcare Company Slides: Q2 2026
Acadia Healthcare Company has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2026. Second Quarte...
Acadia Healthcare (NASDAQ: ACHC) Investors: Court Denies Motion to Dismiss Paving Way for Litigation to Proceed; Contact Robbins LLP for Information About Your Rights
SAN DIEGO--(BUSINESS WIRE)---- $ACHC #Medicine--Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC)...
Acadia Healthcare Announces Date for Second Quarter 2026 Earnings Release
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its second quarter 2026 results on Tuesday, July 28, 2026, after the close of the ...
Acadia Healthcare Company Earnings Call Transcript: Q1 2026
Revenue and Adjusted EBITDA exceeded guidance in Q1 2026, driven by strong acute and RTC performance. Full-year Adjusted EBITDA and EPS guidance were raised, while operational improvements and leadership changes support continued growth.
Acadia Healthcare Company Earnings release: Q1 2026
Acadia Healthcare Company released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Acadia Healthcare Company Slides: Q1 2026
Acadia Healthcare Company has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Acadia Healthcare Company Quarterly report: Q1 2026
Acadia Healthcare Company has published its Q1 2026 quarterly earnings report on April 30, 2026.
Acadia Healthcare Announces First Quarter 2026 Results
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2026. First Quarter...
Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadi...
David Einhorn signals caution as his hedge fund Greenlight prioritizes capital protection
Greenlight Capital's David Einhorn warned that investors may be underestimating potential downside risks. "It probably won't surprise anyone that we are again putting capital preservation at the top o...
Acadia Healthcare Announces Date for First Quarter 2026 Earnings Release
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its first quarter 2026 results on Wednesday, April 29, 2026, after the close of th...
Acadia Healthcare Company Proxy statement: Proxy filing
Acadia Healthcare Company filed a proxy statement on March 25, 2026, providing details for shareholder voting and corporate governance matters.
Acadia Healthcare Company Proxy statement: Proxy filing
Acadia Healthcare Company filed a proxy statement on March 25, 2026, providing details for shareholder voting and corporate governance matters.
Acadia Healthcare Appoints Daniel Cancelmi to Board of Directors
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia”) today announced that it has appointed Daniel Cancelmi to its Board of Directors, effective immediately. Mr. ...
Acadia Healthcare Company Transcript: Barclays 28th Annual Global Healthcare Conference
Leadership changes have energized operations, with a focus on filling 3,000 new beds and improving execution. Demand remains strong, but policy changes and payer scrutiny present headwinds. Expense management and capital deployment prioritize debt reduction and operational efficiency.
Acadia Healthcare Company Transcript: Leerink Global Healthcare Conference 2026
Leadership is driving organizational changes to improve execution and facility performance, with a focus on maximizing existing assets and reducing costs. Financial guidance is conservative, prioritizing debt reduction as CapEx declines, while risk management addresses rising malpractice claims and payer challenges.
Acadia Healthcare Company Transcript: 47th Annual Raymond James Institutional Investor Conference
A leading behavioral health provider outlined its focus on patient care, operational excellence, and ramping new bed capacity, with 2026 revenue guidance of $3.37–$3.45 billion and significant CapEx reductions. Quality outcomes and payer relationships are key, while legal expenses are expected to decline.
Acadia Healthcare Company Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 saw solid revenue and EBITDA growth, with expansion through joint ventures and disciplined capital allocation. 2026 guidance anticipates modest volume growth, lower CapEx, and a focus on operational excellence amid regulatory and payer headwinds, especially from New York Medicaid changes.